Results 151 to 160 of about 1,977 (181)

Nusinersen/onasemnogene-abeparvovec/risdiplam

Reactions Weekly, 2022
openaire   +1 more source

Risdiplam bei SMA zugelassen

NeuroTransmitter, 2021
openaire   +1 more source

New results for risdiplam in spinal muscular atrophy

The Lancet Neurology, 2022
openaire   +2 more sources

Orale Therapie der SMA mit Spleißmodulator Risdiplam

DNP - Der Neurologe & Psychiater, 2022
Svenja Brakemeier, Tim Hagenacker
openaire   +1 more source

AEs of nusinersen, risdiplam and onasemnogene abeparvovec

Reactions Weekly, 2023
openaire   +1 more source

Risdiplam bei präsymptomatischen Säuglingen mit SMA

NeuroTransmitter, 2022
openaire   +1 more source

Beschleunigtes Zulassungsverfahren für Risdiplam

Pädiatrie, 2020
openaire   +1 more source

Positive Langzeitdaten für Risdiplam bei SMA

InFo Neurologie + Psychiatrie, 2023
openaire   +1 more source

Risdiplam : Aus Expertensicht

2021
Rosales, Juan Muñoz, Kölbel, Heike, Hagenacker, Tim, Schara-Schmidt, Ulrike   +3 more
openaire   +2 more sources

Risdiplam distributes and increases SMN protein in both the central nervous system and peripheral organs

Pharmacology Research and Perspectives, 2018
Agnes Poirier, Hasane Ratni
exaly